Methods for diagnosing and evaluating cancer

G - Physics – 01 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

G01N 33/574 (2006.01) C07K 14/705 (2006.01) C12Q 1/68 (2006.01) G01N 33/577 (2006.01) G01N 33/68 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2328112

Methods for diagnosing cancer, such as prostate, ovarian or breast cancer, as well as leukemia, are provided. Such methods may employ binding agents, such as antibodies or CAR sequences of OB-cadherin or N-cadherin, that specifically bind to OB-cadherin or N-cadherin, or polynucleotides that hybridize to a polynucleotide encoding OB-cadherin or N-cadherin. Also provided are methods for monitoring the progression of a cancer and to evaluate the metastatic potential of a cancer.

Procédés servant à diagnostiquer le cancer, tel que le cancer de la prostate, des ovaires ou du sein, ainsi que la leucémie. Ces procédés peuvent mettre en application des agents de liaison, tels que des anticorps ou des séquences de CAR de OB-cadhérine ou N-cadhérine se fixant spécifiquement à OB-cadhérine ou N-cadhérine, ou des polynucléotides s'hybridant à un polynucléotide codant OB-cadhérine ou N-cadhérine. Procédés servant à contrôler la progression d'un cancer et à évaluer le potentiel métastatique d'un cancer.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Methods for diagnosing and evaluating cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods for diagnosing and evaluating cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for diagnosing and evaluating cancer will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2030437

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.